Search

Search Constraints

You searched for: Author/Creator Pusic, Iskra

Search Results

1. A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML. Issue 8 (28th April 2014)

2. A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia. Issue 3 (3rd March 2016)

3. Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study. Issue 10 (1st April 2023)

5. Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement. (10th September 2020)

6. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. (14th December 2021)

7. Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia. (2021)

8. Impact of a 40‐Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia. (December 2021)

9. Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. Issue 29 (10th October 2021)

10. Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen. (23rd October 2017)